Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Omekal Omeprazole 40mg Injection:
Omekal Omeprazole 40mg Injection is a potent medication designed to reduce the production of stomach acid. Belonging to the proton pump inhibitor (PPI) class, this injection is used to treat conditions where reducing stomach acid can prevent injury to the digestive tract. Omekal is trusted for its fast-acting and long-lasting relief from acid-related disorders.
Uses of Omekal Omeprazole 40mg Injection:
Gastroesophageal Reflux Disease (GERD): Helps manage GERD by reducing acid reflux, thereby alleviating symptoms like heartburn and regurgitation.
Peptic Ulcers: Treats and promotes the healing of ulcers in the stomach and the upper part of the small intestine.
Zollinger-Ellison Syndrome: Manages this rare condition where the stomach produces excessive acid.
Other Acid-Related Disorders: Effective in treating other conditions where the reduction of stomach acid is beneficial, such as erosive esophagitis and stress ulcer prophylaxis.
Benefits of Omekal Omeprazole 40mg Injection:
Rapid Relief: Provides quick relief from symptoms associated with high stomach acid.
Promotes Healing: Facilitates the healing process of the gastrointestinal tract by reducing acid production.
Convenient Administration: Injectable form ensures direct and fast action, especially beneficial for patients who cannot take oral medication.
Long-Lasting Effect: Provides extended relief from acid-related symptoms with just one injection.
Mechanism of Omekal Omeprazole 40mg Injection:
Omekal Omeprazole 40mg Injection works by inhibiting the hydrogen-potassium ATPase enzyme, commonly known as the proton pump, located on the parietal cells of the stomach lining. This inhibition prevents the final step of gastric acid production, leading to a significant reduction in acid secretion. By decreasing stomach acid, Omekal alleviates symptoms of acid-related conditions and supports the healing of the affected areas in the gastrointestinal tract.